eli lilly news glp-1 New clinical trial data from shows its daily weight loss pill can reduce body weight by up to 11% over time. ABC medical correspondent Dr. Darien Sutton joins Linsey Davis to Lilly's new GLP-1 pill is

Application to analysis of Clinopodium vulgare L

The combination of the lysosome disruptor siramesine and the tyrosine kinase inhibitor lapatinib increased the expression of TF and reduced the expression of FPN1 in breast cancer cells, thereby promoting iron overload in the lysosome and ultimately inducing ferroptosis (Ma et al., 2016)

Citation95,Citation107111 To test its anti-leishmaniasis effects, Mehrdad Khatami et al biosynthesized FeONPs using Rosemary

The clinical importance of GLP-1 has been highlighted by the development of GLP-1 receptor agonists (such as semaglutide and liraglutide) for managing type 2 diabetes and, under specific NICE criteria, for weight management

We observed a marked decrease of gastric epithelial cell proliferation rates, protection against parietal cell death and a 90% reduction of gastritis, accompanied by normalized expression levels for all (pro-inflammatory) cytokines, confirming the suppression of the host immune response elicited by Helicobacter infection